Publication - Abstract
Nov 29, 2018
Carbohydrate Polymers
Displaying results for your search.
Publication - Abstract
Nov 29, 2018
Carbohydrate Polymers
Publication - Abstract
Jun 13, 2018
Bioconjugate Chemistry
Publication - Abstract
Feb 15, 2018
Vaccine
A cytomegalovirus (CMV) vaccine that is effective at preventing congenital infection and reducing CMV disease in transplant patients remains a high priority as no approved vaccines exist. While the precise correlates of protection are unknown, neut...
Publication - Abstract
Dec 06, 2017
Molecular Therpay
mRNA vaccines are rapidly emerging as a powerful platform for infectious diseases because they are well tolerated, immunogenic, and scalable and are built on precise but adaptable antigen design. We show that two immunizations of modified non-repli...
Publication - Abstract
Nov 13, 2017
Frontiers in Immunology
Modified mRNA vaccines have developed into an effective and well-tolerated vaccine platform that offers scalable and precise antigen production. Nevertheless, the immunological events leading to strong antibody responses elicited by mRNA vaccines a...
Publication - Summary
Jul 13, 2017
Cell
Lately there has been intense effort to develop vaccines for Zika virus, in part due to the recently established link between Zika infection and congenital birth defects such as microcephaly and the rapid spread of Zika in Oceania and the Americas ...
Publication - Summary
Apr 27, 2017
Molecular Therapy
The swine influenza pandemic of 2009 and more recent zoonotic transmissions of several avian influenza subtypes to human populations punctuates the threat posed by new pathogens for which we have no pre-existing immunity. Traditional vaccines requi...
Publication - Summary
Feb 17, 2017
Cell
In the recent years, Zika virus (ZIKV) infection has become a global health threat. This infection has been known to cause multiple symptoms in adults including myalgia and conjunctivitis. More recent studies have also linked ZIKV with congenital m...
Publication - Abstract
Oct 08, 2016
Vaccine Adjuvants
A wide range of studies have shown that liposomes can act as suitable adjuvants for a range of vaccine antigens. Properties such as their amphiphilic character and biphasic nature allow them to incorporate antigens within the lipid bilayer, on the ...
Publication - Abstract
Apr 01, 2016
Advanced Drug Delivery Reviews
Liposomes not only offer the ability to enhance drug delivery, but can effectively act as vaccine delivery systems and adjuvants. Their flexibility in size, charge, bilayer rigidity and composition allow for targeted antigen delivery via ...
Video
Aug 10, 2017
Derek O’Hagan, Global Head of Vaccine Chemistry and Formulation GSK vaccines Research in Cambridge | 2nd Annual Nanomedicines Symposium, July 15th, 2017
Video
Nov 30, 2016
From our 2016 Nanomedicines Symposium in LONDON, UK NOVEMBER 29th, 2016
Video
Jul 26, 2016
Microfluidics in manufacturing of mRNA Nanomedicines | Heinrich Haas, BioNTech
Video
Nov 30, 2016
Nanomedicines Symposium
Jaroslav Turanek - Veterinary Research Institute, Brno Czech Republic -
Video
Nov 30, 2016
Nanomedicines Symposium, London UK November 29th, 2016
Yvonne Perrie, Strathclyde University - Lab-on-Bench Production of Vaccine Adjuvants
Webinar
Nov 08, 2017
Discover how nanoparticles can deliver vaccines and elicit immune responses and see some of the latest research on mRNA vaccines and immuno-oncology therapeutics. Share this video with others who are interested in the latest in vaccine research.